Rituximab sensitizes a Burkitt lymphoma cell line to cell killing by X-irradiation

Radiation and Environmental Biophysics

Volumn 48, Issue 4, 2009, Pages 371-378

  Fengling, Min ^a,b   Fenju, Liu ^a   Wanxin, Wen ^a   Lijia, Zhai ^b   Jiandong, Tong ^b   Zu, Wang ^b   Xin, Yuan ^b   Qingxiang, Gao ^c  

^a SOOCHOW UNIVERSITY   (China)

^b Medical College of Southeast University   (China)

^c LANZHOU UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AFTER-TREATMENT; APOPTOSIS; APOPTOTIC CELL DEATH; APOPTOTIC CELLS; CELL CYCLE; CELL KILLING; CLINICAL TRIAL; COMBINATION TREATMENTS; G2/M CELL CYCLE ARREST; IN-CELL; IN-VITRO; LYMPHOMA CELLS; OXIDATIVE AGENTS; RADIATION DOSE; RAJI CELLS; REACTIVE OXYGEN SPECIES; X-IRRADIATION;

ANTIBODIES; CELL CULTURE; CELL DEATH; CELL GROWTH; CELL MEMBRANES; GROWTH KINETICS; IRRADIATION; OXYGEN;

RADIATION;

HYDROGEN PEROXIDE; REACTIVE OXYGEN METABOLITE; RITUXIMAB;

APOPTOSIS; ARTICLE; BURKITT LYMPHOMA; CELL CYCLE ARREST; CELL DEATH; CELL KILLING; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; GROWTH INHIBITION; HUMAN; HUMAN CELL; IRRADIATION; LYMPHOMA CELL LINE; MULTIMODALITY CANCER THERAPY; RADIATION DOSE; RADIOSENSITIZATION; RAJI CELL; X IRRADIATION;

ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; APOPTOSIS; BURKITT LYMPHOMA; CELL COUNT; CELL CYCLE; CELL DEATH; CELL LINE, TUMOR; CELL SURVIVAL; HUMANS; HYDROGEN PEROXIDE; KINETICS; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; SPECTROMETRY, FLUORESCENCE; X-RAYS;

EID: 70350596485     PISSN: 0301634X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00411-009-0237-9     Document Type: Article

References (31)

1. S Alas C Emmanouilides B Bonavida 2001 Inhibition of interleukin 10 by rituximab results in down-regulation of bcl-2 and sensitization of B-cell non-Hodgkin's lymphoma to apoptosis Clin Cancer Res 7 709 723
2. B Bellosillo N Villamor A López-Guillermo S Marcé J Esteve E Campo D Colomer E Montserrat 2001 Complement-mediated cell death induced by rituximab in B-cell lymphoproliferative disorders is mediated in vitro by a caspase-independent mechanism involving the generation of reactive oxygen species Blood 98 2771 2777 10.1182/blood.V98.9.2771
3. NL Berinstein AJ Grillo-López CA White I Bence-Bruckler D Maloney M Czuczman D Green J Rosenberg P McLaughlin D Shen 1998 Association of serum Rituximab (IDEC-C2B8) concentration and anti-tumor response in the treatment of recurrent low-grade or follicular non-Hodgkin's lymphoma Ann Oncol 9 995 1001 10.1023/A:1008416911099 (Pubitemid 28496709)
4. S Boehrer D Nowak D Hoelzer PS Mitrou KU Chow 2006 Novel agents aiming at specific molecular targets increase chemosensitivity and overcome chemoresistance in hematopoietic malignancies Curr Pharm Des 12 111 128 10.2174/138161206780574588
5. 2: relevance to redox signalling in apoptosis Biochem Soc Symp 71 97 106
6. C Buske O Weigert M Dreyling M Unterhalt W Hiddemann 2006 Current status and perspective of antibody therapy in follicular lymphoma Haematologica 91 104 112
7. ZG Cui T Kondo LB Feril Jr K Waki O Inanami M Kuwabara 2004 Effects of antioxidants on X-ray- or hyperthermia-induced apoptosis in human lymphoma U937 cells Apoptosis 9 757 763 10.1023/B:APPT.0000045782.56480.6b (Pubitemid 40941204)
8. JP Deans L Kalt JA Ledbetter GL Schieven JB Bolen P Johnson 1995 Association of 75/80-kDa phosphoproteins and the tyrosine kinases Lyn, Fyn, and Lck with the B cell molecule CD20. Evidence against involvement of the cytoplasmic regions of CD20 J Biol Chem 270 22632 22638 10.1074/jbc.270.38.22632
9. CE Dearden 2007 Role of antibody therapy in lymphoid malignancies Br Med Bull 83 275 290 10.1093/bmb/ldm025 (Pubitemid 47616189)
10. F Esposito G Chirico N Montesano Gesualdi I Posadas R Ammendola T Russo G Cirino F Cimino 2003 Protein kinase B activation by reactive oxygen species is independent of tyrosine kinase receptor phosphorylation and requires SRC activity J Biol Chem 278 20828 20834 10.1074/jbc.M211841200 (Pubitemid 36806388)
11. JP Fruehauf FL Meyskens Jr 2007 Reactive oxygen species: a breath of life or death? Clin Cancer Res 13 789 794 10.1158/1078-0432.CCR-06-2082 (Pubitemid 46340350)
12. D Gupta ME Crosby A Almasan RM Macklis 2008 Regulation of CD20 expression by radiation-induced changes in intracellular redox status Free Radic Biol Med 44 614 623 10.1016/j.freeradbiomed.2007.10.048
13. Y Hosokawa L Tanaka M Kaneko Y Sakakura E Tsuruga K Irie T Yajima 2002 Apoptosis induced by generated OH radicals inside cells after irradiation Arch Histol Cytol 65 301 305 10.1679/aohc.65.301 (Pubitemid 36019149)
14. AR Jazirehi 2004 Inhibition of the Raf-MEK1/2-ERK1/2 signaling pathway, Bcl-xL down-regulation, and chemosensitization of non-Hodgkin's lymphoma B cells by Rituximab Cancer Res 64 7117 7126 10.1158/0008-5472.CAN-03-3500 (Pubitemid 39331025)
15. VE Kagan GG Borisenko YY Tyurina VA Tyurin J Jiang AI Potapovich V Kini AA Amoscato Y Fujii 2004 Oxidative lipidomics of apoptosis: redox catalytic interactions of cytochrome c with cardiolipin and phosphatidylserine Free Radic Biol Med 37 1963 1985 10.1016/j.freeradbiomed.2004.08.016 (Pubitemid 39491317)
16. NS Kapadia JM Engles RL Wahl 2008 In vitro evaluation of radioprotective and radiosensitizing effects of rituximab J Nucl Med 49 674 678 10.2967/jnumed.107.043752
17. R Mustonen G Bouvier G Wolber M Stöhr P Peschke H Bartsch 1999 A comparison of gamma and neutron irradiation on Raji cells: effects on DNA damage, repair, cell cycle distribution and lethality Mutat Res 429 169 179
18. B Pauwels AE Korst CM de Pooter GG Pattyn HA Lambrechts MF Baay F Lardon JB Vermorken 2003 Comparison of the sulforhodamine B assay and the clonogenic assay for in vitro chemoradiation studies Cancer Chemother Pharmacol 51 221 226
19. B Pauwels AE Korst GG Pattyn HA Lambrechts JA Kamphuis CM De Pooter GJ Peters F Lardon JB Vermorken 2006 The relation between deoxycytidine kinase activity and the radiosensitising effect of gemcitabine in eight different human tumour cell lines BMC Cancer 6 142 10.1186/1471-2407-6-142 (Pubitemid 44110474)
20. IJ Popoff JA Savage J Blake P Johnson JP Deans 1998 The association between CD20 and Src-family tyrosine kinases requires an additional factor Mol Immunol 35 207 214 10.1016/S0161-5890(98)00042-X (Pubitemid 28374928)
21. AM Ramos C Fernández D Amrán P Sancho E de Blas P Aller 2005 Pharmacologic inhibitors of PI3K/Akt potentiate the apoptotic action of the antileukemic drug arsenic trioxide via glutathione depletion and increased peroxide accumulation in myeloid leukemia cells Blood 105 4013 4020 10.1182/blood-2004-07-2802 (Pubitemid 40656150)
22. AM Ristić-Fira IM Petrović LB Korićanac LM Valastro G Privitera G Cuttone 2008 Assessment of the inhibitory effects of different radiation qualities or chemotherapeutic agents on a human melanoma cell line Phys Med 24 187 195
23. C Simoens JB Vermorken AE Korst B Pauwels CM De Pooter GG Pattyn HA Lambrechts F Breillout F Lardon 2006 Cell cycle effects of vinflunine, the most recent promising Vinca alkaloid, and its interaction with radiation, in vitro Cancer Chemother Pharmacol 58 210 218 10.1007/s00280-005-0147-8
24. I Skvortsova BA Popper S Skvortsov M Saurer T Auer R Moser H Kamleitner H Zwierzina P Lukas 2005 Pretreatment with rituximab enhances radiosensitivity of non-Hodgkin's lymphoma cells J Radiat Res (Tokyo) 46 241 248 10.1269/jrr.46.241 (Pubitemid 41190661)
25. I Skvortsova S Skvortsov BA Popper A Haidenberger M Saurer AR Gunkel H Zwierzina P Lukas 2006 Rituximab enhances radiation-triggered apoptosis in non-Hodgkin's lymphoma cells via caspase-dependent and -independent mechanisms J Radiat Res (Tokyo) 47 183 196 10.1269/jrr.47.183 (Pubitemid 44034037)
26. TL Unruh H Li CM Mutch N Shariat L Grigoriou R Sanyal CB Brown JP Deans 2005 Cholesterol depletion inhibits src family kinase-dependent calcium mobilization and apoptosis induced by rituximab crosslinking Immunology 116 223 232 10.1111/j.1365-2567.2005.02213.x (Pubitemid 41368664)
27. GD Wilson 2004 Radiation and the cell cycle, revisited Cancer Metastasis Rev 23 209 225 10.1023/B:CANC.0000031762.91306.b4 (Pubitemid 38881807)
28. JN Winter EA Weller SJ Horning M Krajewska D Variakojis TM Habermann RI Fisher PJ Kurtin WR Macon M Chhanabhai RE Felgar ED His LJ Medeiros JK Weich JC Reed RD Gascoyne 2006 Prognostic significance of Bcl-6 protein expression in DLBCL treated with CHOP or R-CHOP: a prospective correlative study Blood 107 4207 4213 10.1182/blood-2005-10-4222 (Pubitemid 43801342)
29. JH Woo YH Kim YJ Choi DG Kim KS Lee JH Bae DS Min JS Chang YJ Jeong YH Lee JW Park TK Kwon 2003 Molecular mechanisms of curcumin-induced cytotoxicity: induction of apoptosis through generation of reactive oxygen species, down-regulation of Bcl-XL and IAP, the release of cytochrome c and inhibition of Akt Carcinogenesis 24 1199 1208 10.1093/carcin/bgg082 (Pubitemid 36927060)
30. SR Yan G Berton 1996 Regulation of Src family tyrosine kinase activities in adherent human neutrophils. Evidence that reactive oxygen intermediates produced by adherent neutrophils increase the activity of the p58c-fgr and p53/56lyn tyrosine kinases J Biol Chim 271 23464 23471 10.1074/jbc.271.38.23464 (Pubitemid 26314797)
31. J Yi F Gao G Shi H Li Z Wang X Shi X Tang 2002 The inherent cellular level of reactive oxygen species: one of the mechanisms determining apoptotic susceptibility of leukemic cells to arsenic trioxide Apoptosis 7 209 215 10.1023/A:1015331229263 (Pubitemid 34633460)